Invention Grant
- Patent Title: 6-aminoisoquinoline compounds
- Patent Title (中): 6-氨基异喹啉化合物
-
Application No.: US13017708Application Date: 2011-01-31
-
Publication No.: US08357699B2Publication Date: 2013-01-22
- Inventor: Mitchell A. deLong , Susan M. Royalty , Jill Marie Sturdivant , Geoffrey Richard Heintzelman
- Applicant: Mitchell A. deLong , Susan M. Royalty , Jill Marie Sturdivant , Geoffrey Richard Heintzelman
- Applicant Address: US NC Research Triangle Park
- Assignee: Aerie Pharmaceuticals, Inc.
- Current Assignee: Aerie Pharmaceuticals, Inc.
- Current Assignee Address: US NC Research Triangle Park
- Agency: Michael Best & Friedrich LLP
- Main IPC: C07D217/02
- IPC: C07D217/02 ; A61K31/4709
Abstract:
6-Amino isoquinoline compounds are provided that influence, inhibit or reduce the action of a kinase. Pharmaceutical compositions including therapeutically effective amounts of the 6-aminoisoquinoline compounds and pharmaceutically acceptable carriers are also provided. Various methods using the compounds and/or compositions to affect disease states or conditions such as cancer, obesity and glaucoma are also provided.
Public/Granted literature
- US20110183965A1 6-AMINOISOQUINOLINE COMPOUNDS Public/Granted day:2011-07-28
Information query
